全球骨骼切片檢查市場

預計到 2030 年全球骨骼切片檢查市場規模將達到 8.63 億美元

全球骨骼切片檢查市場規模預計在2024年為6.959億美元，預計到2030年將達到8.63億美元，在2024-2030年的分析期內，複合年成長率為3.7%。報告分析的細分市場之一—針刺活體組織切片，預計其複合年成長率為2.9%，到分析期結束時將達到5.314億美元。開放式切片檢查細分市場在分析期間內的複合年成長率預計為4.9%。

美國市場規模估計為 1.896 億美元，中國市場預計複合年成長率為 6.6%

美國切片檢查市場規模預計在2024年達到1.896億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到1.718億美元，在2024-2030年的分析期間內，複合年成長率為6.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為1.5%和2.8%。在歐洲，預計德國的複合年成長率為2.1%。

全球骨骼切片檢查市場—主要趨勢和促進因素摘要

為什麼骨骼切片檢查在現代診斷醫學中變得越來越重要？

骨骼切片檢查正成為診斷醫學的基石，尤其是在評估病因不明的骨骼病變、持續性骨痛和疑似惡性腫瘤。它在識別骨癌、轉移性腫瘤、骨髓炎等感染疾病以及骨質疏鬆症和柏哲氏病病等代謝性骨病等病理方面發揮關鍵作用。與提供結構性資訊的影像技術相比，骨骼切片檢查可以直接取樣組織，從而透過組織病理學和分子生物學分析進行確診。由於癌症發病率的上升，尤其是經常擴散至骨骼的轉移性癌症（例如乳癌、前列腺癌和肺癌），對骨骼切片檢查進行準確和早期診斷的需求至關重要。切片檢查不僅可以確認惡性腫瘤的存在，還有助於確定腫瘤的來源、惡性程度和潛在的治療反應。針切片檢查技術（例如粗針切片和細針抽吸）的進步，使得該操作的創傷性更小，在臨床實踐中更容易獲得。此外，CT和MRI引導切片檢查等影像引導技術的出現，提高了活體組織切片的準確性，並降低了風險。隨著個人化醫療的日益普及，骨骼切片檢查對於獲取組織進行基因組和生物標記分析也至關重要，這進一步提升了其診斷價值。隨著醫療保健系統越來越重視早期療育、標靶治療和經濟高效的診斷，骨骼切片檢查正逐漸成為腫瘤科、整形外科和感染疾病管理領域的重要工具。

科技進步如何徹底改變骨骼切片檢查程序？

技術創新顯著提高了骨骼切片檢查程序的安全性、準確性和臨床效用。雖然傳統的開放性手術切片檢查仍用於複雜病例，但它們正迅速被微創經皮手術所取代，微創經皮手術可縮短恢復時間、降低併發症風險並提高患者舒適度。 CT、螢光透視和 MRI 等成像方式與先進的切片穿刺針結合使用，可即時可視化病灶並精確放置針頭。這種組合確保了高品質的樣本採集，同時最大限度地減少了對周圍組織的損傷。機器人和導航輔助技術開始被納入骨骼切片檢查工作流程，提供亞毫米級的精度，並能夠在脊柱和骨盆等解剖學上具有挑戰性的位置切片檢查。此外，人們正在探索 3D 成像和擴增實境(AR) 平台用於術前規劃和即時引導。在實驗室方面，數位病理學、次世代定序（NGS）和分子診斷正在改變檢體的分析方式，從而能夠識別基因突變、分子標靶和預測性生物標記。這些技術創新使臨床醫生能夠制定高度個人化的治療策略，尤其是在癌症治療方面。電子健康記錄（EHR）和診斷平台的整合確保了無縫的資料傳輸和多學科協作。因此，診斷程序不僅更有效率，而且資訊量更大，從而能夠更深入地了解疾病的發病機制和進展。這種技術與診斷的融合使骨骼切片檢查成為一種高度準確的測試，可為現代治療決策提供關鍵資訊。

疾病流行病學和醫療保健實踐的變化如何影響骨骼切片檢查市場？

疾病模式的改變和醫療保健服務模式的演變正在推動市場格局的轉變。全球癌症發生率的上升，尤其是在老齡化社會中，是推動能夠評估骨骼病變的診斷程序需求成長的主要因素。同樣，已開發經濟體和新興經濟體中慢性骨感染疾病和代謝性疾病的增加也正在創造新的需求管道。例如，糖尿病患者往往易患足部感染疾病和骨髓炎，這些疾病需要準確的診斷和針對性的治療。此外，門診病人和流動醫療的興起推動了微創骨切片檢查技術的應用，該技術能夠在當天以最少的資源進行臨床應用。這種轉變降低了醫療成本，提高了病患吞吐量，同時又不影響診斷品質。同時，人們越來越重視早期發現和篩檢，尤其是對於那些因骨骼相關惡性腫瘤和全身性疾病而面臨骨骼併發症高風險的患者。國家衛生組織和癌症倡導團體正在宣傳早期切片檢查在改善存活率和治療效果方面的益處。新興市場診斷基礎設施、臨床醫生培訓以及患者獲得專科護理的管道的逐步改善，為骨骼切片檢查市場帶來了新的成長機會。此外，公立醫療機構與私人診斷實驗室之間的合作正在完善轉診系統，擴大診斷覆蓋範圍。這些因素共同作用，使骨骼切片檢查能夠深度融入常規診斷護理和慢性病管理。

推動全球骨骼切片檢查市場成長的關鍵因素有哪些？

全球骨骼切片檢查市場的成長受到臨床、技術、人口和經濟等多種因素的協同效應驅動。其中一個最重要的促進因素是全球癌症（尤其是晚期惡性腫瘤）相關骨轉移負擔的持續加重。隨著對準確且經組織學確診的診斷的需求不斷成長，對高效、微創的切片檢查程序的需求也日益成長。隨著影像引導程序的廣泛應用和技術先進的醫療設施的普及，骨骼切片檢查變得比以往任何時候都更安全、更快捷、更容易獲得。病理學服務的改進和分子診斷的整合也鼓勵臨床醫生利用切片檢查進行個人化治療計劃，尤其是在腫瘤學領域。這是因為老年人口更容易出現骨脆性、溶骨性病變和代謝性骨病，因此需要基於組織的診斷。人們對肌肉骨骼健康的認知不斷提高以及政府對醫療保健基礎設施的投資正在支持包括骨骼切片檢查在內的診斷服務的擴展，尤其是在亞太地區、拉丁美洲和中東地區。價值導向醫療的興起以及對早期療育的日益重視，促使醫療保健提供者將骨骼切片檢查作為一種經濟有效的工具，以防止誤診和延遲治療。此外，醫療設備製造商也在切片穿刺針設計、影像相容性和樣本儲存方面不斷創新，以實現更準確、更可靠的操作。隨著患者對微創、更快捷、更個人化醫療的期望不斷提升，預計骨骼切片檢查需求將穩步成長，使其成為現代診斷和疾病管理的重要組成部分。

部分

類型（針吸活體組織切片、開放性切片檢查）、導引類型（MRI 導引、CT 導引）、最終用戶（醫院/診所最終用戶、門診手術中心最終用戶、其他最終用戶）

受訪公司範例（總合36家）

• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company（BD）
• BIOPSYBELL Srl
• Cardinal Health, Inc.
• Cook Medical LLC
• Devicor Medical Products, Inc.
• DiaSorin SpA
• Hologic, Inc.
• IZI Medical Products
• Kimal PLC
• Laurane Medical LLC
• Meditech Devices Pvt. Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• Moller Medical GmbH
• Olympus Corporation
• Remington Medical, Inc.
• SOMATEX Medical Technologies GmbH
• Stryker Corporation

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 並未遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自全球領域專家的精選內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Bone Biopsy Market to Reach US$863.0 Million by 2030

The global market for Bone Biopsy estimated at US$695.9 Million in the year 2024, is expected to reach US$863.0 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Needle Biopsy, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$531.4 Million by the end of the analysis period. Growth in the Open Biopsy segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$189.6 Million While China is Forecast to Grow at 6.6% CAGR

The Bone Biopsy market in the U.S. is estimated at US$189.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$171.8 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Bone Biopsy Market - Key Trends & Drivers Summarized

Why Is Bone Biopsy Gaining Critical Importance in Modern Diagnostic Medicine?

Bone biopsy is increasingly becoming a cornerstone of diagnostic medicine, particularly in the evaluation of unexplained bone lesions, persistent bone pain, or suspected malignancies. It plays a vital role in identifying conditions such as bone cancer, metastatic tumors, infections like osteomyelitis, and metabolic bone disorders such as osteoporosis and Paget’s disease. In contrast to imaging techniques that provide structural insights, a bone biopsy allows for direct tissue sampling, offering a definitive diagnosis through histopathological and molecular analysis. With the growing prevalence of cancer, especially metastatic cancers that frequently spread to the bones (e.g., breast, prostate, and lung cancer), the need for accurate and early diagnosis via bone biopsy has become paramount. It not only helps in confirming the presence of malignancy but also in determining the origin, grade, and potential treatment responses of the tumor. Advances in needle-based biopsy methods, including core needle and fine needle aspiration, have made the procedure less invasive and more accessible across clinical settings. Furthermore, the increasing availability of image-guided techniques such as CT and MRI-guided biopsies has improved precision and reduced procedural risks. As personalized medicine becomes more prominent, bone biopsies are also essential for collecting tissue needed for genomic and biomarker analysis, further enhancing their diagnostic value. With healthcare systems increasingly focusing on early intervention, targeted therapy, and cost-effective diagnostics, bone biopsy is emerging as an essential tool across oncology, orthopedics, and infectious disease management.

How Are Technological Advancements Revolutionizing Bone Biopsy Procedures?

Technological innovations are significantly enhancing the safety, accuracy, and clinical utility of bone biopsy procedures. Traditional open surgical biopsies, while still in use for complex cases, are rapidly being replaced by minimally invasive percutaneous techniques that offer shorter recovery times, lower risk of complications, and higher patient comfort. Imaging modalities such as CT, fluoroscopy, and MRI are being used in tandem with advanced biopsy needles to allow for real-time visualization of the lesion and precise needle placement. This combination minimizes damage to surrounding tissues while ensuring high-quality sample collection. Robotics and navigation-assisted technologies are beginning to be integrated into bone biopsy workflows, offering sub-millimeter accuracy and enabling biopsies in anatomically challenging locations, such as the spine or pelvis. Additionally, 3D imaging and augmented reality platforms are being explored for pre-procedural planning and real-time guidance. On the laboratory side, digital pathology, next-generation sequencing (NGS), and molecular diagnostics are transforming how bone biopsy specimens are analyzed, allowing for the identification of genetic mutations, molecular targets, and predictive biomarkers. These innovations enable clinicians to develop highly individualized treatment strategies, especially in cancer care. The integration of electronic health records (EHRs) with diagnostic platforms ensures seamless data transfer and multidisciplinary collaboration. As a result, the procedure is not only becoming more efficient but also more informative, providing deeper insights into disease pathology and progression. This fusion of technology and diagnostics is positioning bone biopsy as a high-precision procedure that delivers critical information to guide modern therapeutic decisions.

How Are Shifts in Disease Epidemiology and Healthcare Practices Impacting the Bone Biopsy Market?

Changing disease patterns and evolving healthcare delivery models are reshaping the landscape of the bone biopsy market. The global increase in cancer incidence, especially among aging populations, is a primary factor driving the demand for diagnostic procedures capable of evaluating bone involvement. Similarly, the rise of chronic bone infections and metabolic disorders in both developed and emerging economies is creating new demand channels. Patients with diabetes, for instance, are more prone to foot infections and osteomyelitis, conditions that often require bone biopsy for accurate diagnosis and targeted treatment. In addition, the push toward outpatient and ambulatory care is facilitating the use of minimally invasive bone biopsy techniques that can be performed in same-day clinical settings with minimal resources. This transition reduces healthcare costs and improves patient throughput without compromising diagnostic quality. In parallel, there is an increasing emphasis on early detection and screening, particularly for individuals at high risk of bone-related malignancies or skeletal complications from systemic diseases. National health agencies and cancer advocacy groups are promoting awareness about the benefits of early biopsy in improving survival and treatment efficacy. In developing regions, gradual improvements in diagnostic infrastructure, clinician training, and patient access to specialty care are opening up new growth opportunities for the bone biopsy market. Additionally, collaborations between public health institutions and private diagnostic labs are leading to improved referral systems and broader diagnostic reach. All of these factors are converging to integrate bone biopsy more deeply into the fabric of routine diagnostic medicine and chronic disease management.

What Key Factors Are Driving the Growth of the Global Bone Biopsy Market?

The growth in the global bone biopsy market is driven by a synergy of clinical, technological, demographic, and economic factors. One of the most significant drivers is the rising global burden of cancer, especially bone metastases associated with advanced-stage malignancies. As the demand for precise, histologically confirmed diagnoses increases, so does the need for efficient and minimally invasive biopsy procedures. The widespread adoption of image-guided techniques and the proliferation of technologically advanced healthcare facilities are making bone biopsy safer, faster, and more accessible than ever before. Improvements in pathology services and the integration of molecular diagnostics are also encouraging clinicians to rely on bone biopsy for personalized treatment planning, particularly in oncology. The global aging population is another key driver, as older adults are more prone to bone fragility, osteolytic lesions, and metabolic bone diseases that require tissue-based diagnosis. Growing awareness of musculoskeletal health and government investments in healthcare infrastructure-especially in Asia-Pacific, Latin America, and the Middle East-are supporting the expansion of diagnostic services, including bone biopsies. The rise of value-based care and a stronger focus on early intervention have incentivized healthcare providers to adopt bone biopsy as a cost-effective tool for preventing misdiagnoses and treatment delays. Furthermore, medical device manufacturers are innovating in biopsy needle design, imaging compatibility, and sample preservation, enabling more precise and reliable procedures. As patient expectations evolve toward less invasive, faster, and more personalized care, the demand for bone biopsy is expected to grow steadily, making it a critical component of modern diagnostics and disease management.

SCOPE OF STUDY:

The report analyzes the Bone Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Needle Biopsy, Open Biopsy); Guide Type (MRI-Guided, CT-Guided); End-Use (Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Argon Medical Devices, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• BIOPSYBELL Srl
• Cardinal Health, Inc.
• Cook Medical LLC
• Devicor Medical Products, Inc.
• DiaSorin S.p.A.
• Hologic, Inc.
• IZI Medical Products
• Kimal PLC
• Laurane Medical LLC
• Meditech Devices Pvt. Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• Moller Medical GmbH
• Olympus Corporation
• Remington Medical, Inc.
• SOMATEX Medical Technologies GmbH
• Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Bone Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Bone Disorders and Cancers Throws the Spotlight on Bone Biopsy as a Diagnostic Standard
  • Increased Emphasis on Early Detection Spurs Growth in Biopsy Procedures for Suspected Bone Lesions
  • Here's How Advanced Imaging Integration Is Enhancing Accuracy and Safety of Image-Guided Bone Biopsies
  • Growth in Oncology and Orthopedic Diagnostics Expands Clinical Use of Bone Biopsy Across Healthcare Settings
  • Expansion of Minimally Invasive Procedures Strengthens the Business Case for Needle-Based Core Biopsy Techniques
  • Improved Pathology and Biomarker Analysis Tools Drive Adoption of Bone Biopsy for Personalized Treatment Planning
  • Here's the Story: How Bone Biopsy Is Becoming Central to Diagnosing Rare Bone Tumors and Metabolic Bone Disease
  • Global Growth in Cancer Screening Programs Increases Procedure Volume in Hospital and Diagnostic Labs
  • Rising Awareness Among Clinicians About Bone Marrow vs. Bone Biopsy Indications Enhances Procedural Accuracy
  • Innovation in Biopsy Needle Design and Radiolucent Markers Supports Procedural Efficiency and Patient Comfort
  • Increased Availability of CT and MRI Imaging in Emerging Markets Fuels Adoption of Image-Guided Biopsies
  • Integration with Molecular Testing Expands Role of Bone Biopsy in Precision Oncology and Targeted Therapies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Bone Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Bone Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Needle Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Needle Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Needle Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Open Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Open Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Open Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for MRI-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for MRI-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for MRI-Guided by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for CT-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for CT-Guided by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for CT-Guided by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospital & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospital & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: China 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Bone Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: France 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Germany 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Italy 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: UK 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Spain 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Russia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Bone Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Australia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: India 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: South Korea 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Bone Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Latin America 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Argentina 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Brazil 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Mexico 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Bone Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Middle East 16-Year Perspective for Bone Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Iran 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Israel 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: UAE 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Bone Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Bone Biopsy by Type - Needle Biopsy and Open Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Bone Biopsy by Type - Needle Biopsy and Open Biopsy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Africa 16-Year Perspective for Bone Biopsy by Type - Percentage Breakdown of Value Sales for Needle Biopsy and Open Biopsy for the Years 2014, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Bone Biopsy by Guide Type - MRI-Guided and CT-Guided Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Bone Biopsy by Guide Type - Percentage Breakdown of Value Sales for MRI-Guided and CT-Guided for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Bone Biopsy by End-Use - Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Bone Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospital & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION